The Metabolism of the Catecholamines (Clinical Implications)
Authors: ROBERT A. COHEN
Journal: Annals of Internal Medicine (1962)

Clinical Staff Conference1 June 1962The Metabolism of the Catecholamines (Clinical Implications)Combined Clinical Staff Conference of the National Institutes of HealthROBERT A. COHEN, M.D., WILLIAM F. BRIDGERS, M.D., JULIUS AXELROD, PH.D., HANS WEIL-MALHERBE, M.D., ELWOOD H. LABROSSE, M.D., WILLIAM E. BUNNEY JR., M.D., PHILIPPE V. CARDON JR., M.D., SEYMOUR S. KETY, M.D.ROBERT A. COHEN, M.D., WILLIAM F. BRIDGERS, M.D., JULIUS AXELROD, PH.D., HANS WEIL-MALHERBE, M.D., ELWOOD H. LABROSSE, M.D., WILLIAM E. BUNNEY JR., M.D., PHILIPPE V. CARDON JR., M.D., SEYMOUR S. KETY, M.D.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-56-6-960 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptDr. Robert A. Cohen: We wish to present today a review of some of our studies on the metabolism of the catecholamines. We shall begin with a discussion of some basic research on biosynthesis, and on the action of certain psychotropic drugs on the metabolism of the amines, and will then move on to clinical studies in normal controls and patients.We have selected this topic for several reasons. The catecholamines are of great importance to all of us; they are being widely studied throughout the National Institutes of Health, and we believe that it might be interesting to you...References1. ARMSTRONGMCMILLANSHAW MDAKN: 3-methoxy-4-hydroxy-d-mandelic acid, a urinary metabolite of norepinephrine. Biochim. Biophys. Acta 25: 422, 1957. CrossrefMedlineGoogle Scholar2. AXELROD J: O-methylation of epinephrine and other catechols in vitro and in vivo. Science 126: 400, 1957. CrossrefMedlineGoogle Scholar3. AXELRODKOPINMANN JIJJD: 3-methoxy-4-hydroxyphenylglycol sulfate, a new metabolite of epinephrine and norepinephrine. Biochim. Biophys. Acta 36: 576, 1959. CrossrefMedlineGoogle Scholar4. KIRSHNERGOODALLROSEN NML: Metabolism of dl-adrenaline-2-C14 in the human. Proc. Soc. Exp. Biol. Med. 98: 627, 1958. CrossrefMedlineGoogle Scholar5. KOPINAXELROD IJJ: 3,4-dihydroxyphenylglycol, a metabolite of epinephrine. Arch. Biochem. Biophys. 89: 148, 1960. CrossrefMedlineGoogle Scholar6. LABROSSEAXELRODKETY EHJSS: Omethylation, the principal route of metabolism of epinephrine in man. Science 128: 593, 1958. CrossrefMedlineGoogle Scholar7. LABROSSEAXELRODKOPINKETY EHJIJSS: Metabolism of 7-H3-epinephrine-d-bitartrate in normal young men. J. Clin. Invest. 40: 253, 1961. CrossrefMedlineGoogle Scholar8. AXELRODINSCOESENOHWITKOP JJKSB: O-methylation, the principal pathway for the metabolism of epinephrine and norepinephrine in the rat. Biochim. Biophys. Acta 27: 210, 1958. CrossrefMedlineGoogle Scholar9. KOPINAXELRODGORDON IJJE: The metabolic fate of H3-epinephrine and C14-metanephrine in the rat. J. Biol. Chem. 236: 2109, 1961. CrossrefMedlineGoogle Scholar10. LABROSSEAXELRODSJOERDSMA EHJA: Urinary excretion of normetanephrine in man. Fed. Proc. 17: 386, 1958. Google Scholar11. KOPINAXELROD IJJ: Presence of 3-methoxy-4-hydroxyphenylglycol and metanephrine in phaeochromocytoma tissue. Nature 185: 788, 1960. CrossrefMedlineGoogle Scholar12. VON STUDNITZ W: Die Ausscheidung von Metaboliten des Dopa und Dopaminstoffwechseis bei 2 Fällen mit Neuroblastom. Scand. J. Clin. Lab. Invest. 12: supp. 48, p. 58, 1960. Google Scholar13. AXELRODTOMCHICK JR: Enzymatic Omethylation of epinephrine and other catechols. J. Biol. Chem. 233: 702, 1958. CrossrefMedlineGoogle Scholar14. AXELRODALBERSCLEMENTE JWCD: Distribution of catechol-O-methyl transferase in the nervous system and other tissues. J. Neurochem. 5: 68, 1959. CrossrefGoogle Scholar15. GRIESEMERBARSKYDRAGSTEDTWELLSZELLER ECJCAJAEA: Potentiating effect of iproniazid on the pharmacological action of sympathomimetic amines. Proc. Soc. Exp. Biol Med. 84: 699, 1953. CrossrefMedlineGoogle Scholar16. FRIENDZILELIHAMLINREUTTER DGMSJTFW: The effect of iproniazid of the inactivation of norepinephrine in the human. J. Clin. Exp. Psychother. 19: supp. 61, 1958. Google Scholar17. BACQ ZM: Sensibilization a l'adrenaline et a l'excitation des nerfs adrenergiques par les antioxygens. Bull. Acad. Roy. Med. Belgique 15: 627, 1935. Google Scholar18. AXELRODLAROCHE JMJ: Inhibitor of Omethylation of epinephrine and norepinephrine in vitro and in vivo. Science 130: 800, 1959. CrossrefMedlineGoogle Scholar19. BACQGOSSELINDRESSERENSON ZMLAJ: Inhibition of O-methyltransferase by catechol and sensitization to epinephrine. Science 130: 453, 1959. CrossrefMedlineGoogle Scholar20. WYLIEARCHERARNOLD DWSH: Augmentation of pharmacological properties of catecholamines by O-methyl-transferase inhibitors. J. Pharmacol. Exp. Ther. 130: 239, 1961. Google Scholar21. AXELRODWEIL-MALHERBETOMCHICK JHR: The physiological disposition of H3-epinephrine and its metabolite metanephrine. J. Pharmacol. Exp. Ther. 127: 251, 1959. MedlineGoogle Scholar22. WHITBYAXELRODWEIL-MALHERBE LGJH: The fate of H3-norepinephrine in animals. J. Pharmacol. Exp. Ther. 132: 193, 1961. MedlineGoogle Scholar23. WEIL-MALHERBEAXELRODTOMCHICK HJR: Blood-brain barrier for adrenaline. Science 129: 1226, 1959. CrossrefMedlineGoogle Scholar24. VON EULER US: Noradrenaline: Chemistry, Physiology, Pharmacology and Clinical Aspects, Charles C Thomas, Springfield, Ill., 1956. CrossrefGoogle Scholar25. HERTTINGAXELRODKOPINWHITBY GJIJLG: Lack of uptake of catecholamines after chronic denervation of sympathetic nerves. Nature 189: 66, 1961. CrossrefMedlineGoogle Scholar26. HERTTINGAXELROD GJ: The fate of H3-noradrenaline at sympathetic nerve endings. Nature 192: 172, 1961. CrossrefMedlineGoogle Scholar27. HOLZBAUERVOGT MM: Depression by reserpine of the noradrenaline concentration in the hypothalamus of the cat. J. Neurochem. 1: 8, 1956. CrossrefMedlineGoogle Scholar28. CASSKUNTZMANBRODIE RRBB: Norepinephrine depletion as a possible mechanismof action of guanethidine (SU5864), a new hypotensive agent. Proc. Soc. Exp. Biol. Med. 103: 871, 1960. CrossrefMedlineGoogle Scholar29. SHOREMEADKUNTZMANSPECTORBRODIE PAJARGSBB: On the physiologic significance of monoamine oxidase in brain. Science 126: 1063, 1957. CrossrefMedlineGoogle Scholar30. AXELRODWHITBYHERTTING JLGG: Effect of psychotropic drugs on the uptake of H3-norepinephrine by tissues. Science 133: 383, 1961. CrossrefMedlineGoogle Scholar31. HERTTINGAXELRODWHITBY GJLG: Effect of drugs on the uptake and metabolism of H3-norepinephrine. J. Pharmacol. Exp. Ther. 134: 146, 1961. MedlineGoogle Scholar32. AXELRODTOMCHICK JR: Activation and inhibition of adrenaline metabolism. Nature 184: 2027, 1959. CrossrefMedlineGoogle Scholar33. AXELRODTOMCHICK JR: Increased rate of metabolism of epinephrine and norepinephrine by sympathomimetic amines. J. Pharmacol. Exp. Ther. 130: 367, 1960. MedlineGoogle Scholar34. AXELRODHERTTINGPATRICK JGRW: Inhibition of H3-norepinephrine release by monoamine oxidase inhibitors. J. Pharmacol. Exp. Ther. 134: 325, 1961. MedlineGoogle Scholar35. LABROSSEMANNKETY EHJDSS: The physiological and psychological effects of intravenously administered epinephrine, and its metabolism in normal and schizophrenic men. III. Metabolism of 7-H3-epinephrine as determined in studies on blood and urine. J. Psychiat. Res. 1: 68, 1961. CrossrefMedlineGoogle Scholar36. WEIL-MALHERBEBONE HAD: The chemical estimation of adrenalin-like substances in blood. Biochem. J. 51: 311, 1952. CrossrefMedlineGoogle Scholar37. TOLSONGILMOREMASON WWLJW: The measurement of urinary epinephrine and norepinephrine levels in the rhesus monkey. Unpublished observations. Google Scholar38. GLENNNELSON EMDH: Chemical method for the determination of 17-hydroxycorticosteroids and 17-ketosteroids in urine following hydrolysis with beta glucuronidase. J. Clin. Endocr. 13: 911, 1953. CrossrefMedlineGoogle Scholar39. TOLSONMASONSACHARHAMBURGHANDLONFISHMAN WWJWEJDAJHJR: Urinary catecholamine responses associated with hospital admissions in normal human subjects. Unpublished observations. Google Scholar40. BOARDWADESONPERSKY FRH: Depressive affect and endocrine functions. Arch. Neurol. Psychiat. 78: 612, 1957. CrossrefGoogle Scholar41. HAMBURGSABSHINBOARDGRINKERKORCHINBASOWITZHEATHPERSKY DAMAFARRSJHHH: Classification and rating of emotional experiences: special reference to reliability of observations. Arch. Neurol. Psychiat. 79: 415, 1958. CrossrefGoogle Scholar42. WEISEMCDONALDLABROSSE VKRKEH: Determination of urinary 3-methoxy-4-hydroxymandelic acid in man. Clin. Chim. Acta 6: 79, 1961. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: ROBERT A. COHEN, M.D.; WILLIAM F. BRIDGERS, M.D.; JULIUS AXELROD, PH.D.; HANS WEIL-MALHERBE, M.D.; ELWOOD H. LABROSSE, M.D.; WILLIAM E. BUNNEYJR., M.D.; PHILIPPE V. CARDONJR., M.D.; SEYMOUR S. KETY, M.D.Affiliations: Bethesda, MarylandThis is an edited transcription of a combined clinical staff conference at the Clinical Center, Bethesda, Maryland, by the National Institute of Mental Health, National Institutes of Health, Public Health Service, Department of Health, Education, and Welfare.Requests for reprints should be addressed to Robert A. Cohen, M.D., National Institute of Mental Health, Bethesda 14, Maryland. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byThe Biochemistry of the Functional PsychosesChanges of sympathetic activity during tooth extractionTyrosine loading enhances catecholamine excretion by ratsMETHODOLOGICAL CONSIDERATIONS IN PSYCHOENDOCRINE RESEARCH5 The Biosynthesis and Metabolism of the CatecholaminesBiogenic Amines and EmotionHypertonie und erhöhte KatecholaminausscheidungCurrent Experience in the Diagnosis of PheochromocytomaInhibitors of monoamine oxidase and decarboxylase of aromatic amino acidsSimultaneous Urinary Assays for the Combined Metanephrines and 3-Methoxy-4-Hydroxyphenylglycol in Patients with Pheochromocytoma and Primary HypertensionMonoamine-oxidase Inhibitor Reactions Simulating Phenochromocytoma AttacksHERBERT F. R. PLASS, M.D.Electrophoretic separation of catecholamine metabolites and the quantification of norepinephrine-7H3 metabolites in manCurrent Concepts of DepressionSummaryCase 28-1963 1 June 1962Volume 56, Issue 6Page: 960-987KeywordsAttentionBiosynthesisCatecholaminesDrug metabolismDrug regulationDrugsExcretionMedical servicesPrevention, policy, and public healthPsychiatry and mental health ePublished: 1 December 2008 Issue Published: 1 June 1962 PDF downloadLoading ...